„First Line“

Suchergebnisse

3.416 Treffer

• Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors
  Nadler, Eric ; Pavilack, Melissa ; Espirito, Janet L. ; Clark, Jamyia ; Fernandes, Ancilla
• Efficacy and Safety of Approved First-Line Tyrosine Kinase Inhibitor Treatments in Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
  Manz, Kirsi M. ; Fenchel, Klaus ; Eilers, Andreas ; Morgan, Jonathan ; Wittling, Kirsten ; Dempke, Wolfram C. M.
• Model-Based Economic Evaluation of Ceritinib and Platinum-Based Chemotherapy as First-Line Treatments for Advanced Non-Small Cell Lung Cancer in China
  Peng, Ye ; Ma, Fang ; Tan, Chongqing ; Wan, Xiaomin ; Yi, Lidan ; Peng, Liubao ; Zeng, Xiaohui
• Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study
  Broos, Wouter A. M. ; Wondergem, Maurits ; Knol, Remco J. J. ; Zant, Friso M. van der
• Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
  Schremser, Katharina ; Rogowski, Wolf ; Adler-Reichel, Sigrid ; Tufman, Amanda L. H. ; Huber, Rudolf M. ; Stollenwerk, Björn
• Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis
  Fiala, Ondrej ; Veskrnova, Veronika ; Chloupkova, Renata ; Poprach, Alexandr ; Kiss, Igor ; Kopeckova, Katerina ; Dusek, Ladislav ; Slavicek, Lubomir ; Kohoutek, Milan ; Finek, Jindrich ; Svoboda, Marek ; Petruzelka, Lubos ; Boubliková, Ludmila ; Dvorak, Josef ; Melichar, Bohuslav ; Buchler, Tomas
• Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma
  Ishihara, Hiroki ; Takagi, Toshio ; Kondo, Tsunenori ; Fukuda, Hironori ; Yoshida, Kazuhiko ; Iizuka, Junpei ; Tanabe, Kazunari
• Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work
  Harty, Gerard ; Jarrett, James ; Jofre-Bonet, Mireia
• Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma
  Ikeda, Takashi ; Ishihara, Hiroki ; Takagi, Toshio ; Kondo, Tsunenori ; Yoshida, Kazuhiko ; Iizuka, Junpei ; Tanabe, Kazunari
• Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
  Gharaibeh, Mahdi ; McBride, Ali ; Alberts, David S. ; Slack, Marion ; Erstad, Brian ; Alsaid, Nimer ; Bootman, J. Lyle ; Abraham, Ivo
• Cost Effectiveness of Alectinib vs. Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer
  Carlson, Josh J. ; Suh, Kangho ; Orfanos, Panos ; Wong, William
• Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England
  Tikhonova, Irina A. ; Huxley, Nicola ; Snowsill, Tristan ; Crathorne, Louise ; Varley-Campbell, Jo ; Napier, Mark ; Hoyle, Martin
• Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study
  Hagiwara, Yasuhiro ; Shiroiwa, Takeru ; Shimozuma, Kojiro ; Kawahara, Takuya ; Uemura, Yukari ; Watanabe, Takanori ; Taira, Naruto ; Fukuda, Takashi ; Ohashi, Yasuo ; Mukai, Hirofumi
• Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
  McKeage, Mark J. ; Kotasek, Dusan ; Markman, Ben ; Hidalgo, Manuel ; Millward, Michael J. ; Jameson, Michael B. ; Harris, Dean L. ; Stagg, Robert J. ; Kapoun, Ann M. ; Xu, Lu ; Hughes, Brett G. M.
• Treatment Patterns and Outcomes in Patients with KRAS Wild-Type Metastatic Colorectal Cancer Treated in First Line with Bevacizumab- or Cetuximab-Containing Regimens
  Houts, Arthur C. ; Ogale, Sarika ; Sommer, Nicolas ; Satram-Hoang, Sacha ; Walker, Mark S.
• CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer
  Sunakawa, Yu ; Tsuji, Akihito ; Denda, Tadamichi ; Segawa, Yoshihiko ; Negoro, Yuji ; Shimada, Ken ; Kochi, Mitsugu ; Nakamura, Masato ; Kotaka, Masahito ; Tanioka, Hiroaki ; Takagane, Akinori ; Tani, Satoshi ; Yamaguchi, Tatsuro ; Watanabe, Takanori ; Takeuchi, Masahiro ; Fujii, Masashi ; Ichikawa, Wataru
• Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings
  Houts, Arthur C. ; Ogale, Sarika ; Zafar, Yousuf ; Hubbard, Joleen M. ; Satram-Hoang, Sacha ; Sommer, Nicolas ; Walker, Mark S.
• Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
  Li, Na ; Zheng, Bin ; Cai, Hong-Fu ; Yang, Jing ; Luo, Xiao-feng ; Weng, Li-Zhu ; Zhan, Feng-Mei ; Liu, Mao-Bai
• Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
  Grassi, Paolo ; Verzoni, Elena ; Ratta, Raffaele ; Porcu, Luca ; Prisciandaro, Michele ; Mennitto, Alessia ; Calareso, Giuseppina ; Braud, Filippo De ; Procopio, Giuseppe
• Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States
  Huang, Min ; Lou, Yanyan ; Pellissier, James ; Burke, Thomas ; Liu, Frank Xiaoqing ; Xu, Ruifeng ; Velcheti, Vamsidhar